Brigidi Patrizia


Responsabile dell'U.O.

Cognome e Nome

Brigidi Patrizia

Qualifica

PO

Dipartimento

Pharmaceutical Sciences

Settore scientifico disciplinare

CHIM 11

E-mail

patrizia.brigidi@unibo.it

Telefono

Personale strutturato

Cognome e Nome

Di Pietra Anna Maria

Qualifica

PA

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Vitali Beatrice

Qualifica

Ricercatore

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Personale non strutturato

Cognome e Nome

Maccaferri Simone

Qualifica

Post-doc

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Candela Marco

Qualifica

Post-doc

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Biagi Elena

Qualifica

Post-doc

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Turroni Silvia

Qualifica

Post-doc

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Centanni Manuela

Qualifica

Post-doc

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Cognome e Nome

Rampelli Simone

Qualifica

Ph.D student

Dipartimento

Pharmaceutical Sciences

Ente di appartenenza

University of Bologna

Linee di ricerca

1. Microbial characterization of different ecological communities by the employment of a vast array of molecular techniques, including functional and phylogenetic metagenomics, transcriptomics and qPCR. In particular, these approaches have been used to characterize the complex ecosystem represented by the human intestinal microbiota. 2. Using genome sequence data, predicted open reading frames have been searched against known protein and protein motifs databases to identify proteins of probiotic bacteria potentially involved in molecular pathways related to their health-promoting activities. The functional genes have been over-expressed in a heterologous host and their enzymatic activity evaluated by different analytical methods (capillary electrophoresis, spectrophotometry, etc.). 3. Proteomic analysis has been used to catalogue the most abundantly expressed proteins in industrial bacteria. Mass spectrometric identification of the two-dimensional gel-separated proteins and multi-dimensional chromatography coupled with tandem mass spectrometry have been applied for comparative analysis of proteins recovered from bacteria grown in different culture conditions as well as from wild type and mutants. This approach allowed the identification of specific proteins whose expression levels vary in the different strains and culture conditions. 4. Fermentative processes of anaerobic bacteria used in dairy and pharmaceutical products (growth kinetics, productivity and biomass yields) have been studied in batch fermentations. Optimization of fermentative parameters (substrate, pH, pO2, stress condition) was carried out by parallel cultivation experiments performed in 10 small scale bioreactors available in the CIRB laboratory of fermentation. These parallel fermentations allowed the evaluation of the gene expression under different growth conditions.

Tecnologie in uso dall'UO

  1. 1.
    Metagenomics
  2. 2.
    Transcriptomics
  3. 3.
    Molecular phylogenetic tools

Strumentazione

Denominazione

Struttura ove la strumentazione è allocata

Responsabile

Pubblicazioni

  1. 1.
    Maccaferri S., Vitali B., Klinder A., Kolida S., Ndagijimana M., Laghi L., Calanni F., Brigidi P., Gibson G., Costabile A. Rifaximin modulates the colonic microbiota of Crohn’s Disease patients: an in vitro approach using a continuous culture colonic model system. J. Antimicrob. Chemother., 65, 2556–2565, 2010.
  2. 2.
    Candela M., Guidotti M., Fabbri C., Brigidi P., Franceschi C., Fiorentini C. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit. Rev. Microbiol. 37, 1-14, 2011
  3. 3.
    Biagi E., Candela M., Franceschi C., Brigidi P. The aging gut microbiota: new perspectives. Ageing Res Rev., 10, 428-429, 2011.
  4. 4.
    Candela M., Turroni S., Centanni M., Fiori J., Bergmann S., Hammerschmidt S., Brigidi P. Relevance of the Bifidobacterium animalis subsp. lactis plasminogen binding activity in the human gastrointestinal microenvironment. Appl Environ Microbiol., 77,7072-6, 2011.
  5. 5.
    Maccaferri S., Biagi E., Brigidi P. Metagenomics: key to human gut microbiota. Dig. Dis., 29, 525–530, 2011.
  6. 6.
    Biagi E., Candela M., Fairweather-Tait S., Franceschi C., Brigidi P. Aging of the human metaorganism: the microbial counterpart. Age (Dordr), 34, 247-67, 2012.
  7. 7.
    Maccaferri S., Klinder A., Brigidi P., Cavina P., Costabile A. Potential probiotic Kluyveromyces marxianus fragilis B0399 modulates the immune response in Caco-2 cells and PBMCs and impacts on the human gut microbiota in an in vitro colonic model system. Appl Environ Microbiol.,78, 956-64, 2012.
  8. 8.
    Vitali B., Minervini G., Rizzello C.G., Spisni E., Maccaferri S., Brigidi P., Gobbetti M., Di Cagno R. Novel probiotic candidates for humans isolated from raw fruits and vegetables. Food Microbiol., 31,116-125, 2012.
  9. 9.
    Centanni M., Bergmann S., Turroni S., Hammerschmidt S., Chhatwal G., Brigidi P., Candela M. TNF-α modulates the dynamics of the plasminogen-mediated early interaction between Bifidobacterium animalis subsp. lactis and human enterocytes. Appl. Environ. Microbiol., 78, 2465-2469, 2012.
  10. 10.
    Candela M., Rampelli S., Turroni S., Severgnini M., Consolandi C., De Bellis G., Masetti R., Ricci G., Pession A., Brigidi P. Unbalance of Intestinal Microbiota in Atopic Children. BMC Microbiology, 2012 Jun 6;12(1):95.

Dottorati di ricerca

Componente UO

Patrizia Brigidi

Dottorato di ricerca

Scienze Biochimiche e Biotecnologiche

Coordinatore

Santi Spampinato

Sede

Dip. Biochimica "Moruzzi", Bologna